Furthermore, we found that the expression level of IL1B increased with the progression of hepatic carcinoma (Figure 6D), and the results of K-means clustering algorithm showed that IL1B could optimally classify the disease progression status, suggesting that it could be used to supervise the progression of hepatic carcinoma. This evidence concerns the gene IL1B and hepatocellular carcinoma.